tci Part B Insider - 2004 Issue 12

Drug Reimbursement: CMS Boosts Payments For Nine Drugs

Verteporfin, Octreotide among the biggest gainersPhysician practices that have been struggling with low reimbursement for many important drugs since the Medicare Reform law slashed payments across the board can breathe a sigh of relief. In Transmittal R-119-CP, issued March 15, the Centers for Medicare & Medicaid Services boosted payments for nine of the hardest hit drugs. CMS only recently boosted coverage for ocular photodynamic therapy with verteporfin for age-related macular degeneration. CMS settled a lawsuit last May by agreeing to convene a new Medicare Coverage Advisory Committee meeting to evaluate scientific evidence and make recommendations to CMS, particularly...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.